Healthpeak Properties, Inc. $DOC Shares Sold by Lee Danner & Bass Inc.

Lee Danner & Bass Inc. lowered its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 21.5% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 35,312 shares of the real estate investment trust’s stock after selling 9,650 shares during the period. Lee Danner & Bass Inc.’s holdings in Healthpeak Properties were worth $618,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also made changes to their positions in DOC. Cambridge Investment Research Advisors Inc. raised its position in shares of Healthpeak Properties by 6.9% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 357,520 shares of the real estate investment trust’s stock worth $7,229,000 after acquiring an additional 23,135 shares in the last quarter. Sequoia Financial Advisors LLC increased its position in Healthpeak Properties by 11.3% during the first quarter. Sequoia Financial Advisors LLC now owns 89,158 shares of the real estate investment trust’s stock worth $1,803,000 after buying an additional 9,019 shares during the period. Robeco Institutional Asset Management B.V. increased its position in Healthpeak Properties by 9.0% during the first quarter. Robeco Institutional Asset Management B.V. now owns 698,940 shares of the real estate investment trust’s stock worth $14,133,000 after buying an additional 57,985 shares during the period. Illinois Municipal Retirement Fund grew its stake in shares of Healthpeak Properties by 131.7% in the 1st quarter. Illinois Municipal Retirement Fund now owns 514,791 shares of the real estate investment trust’s stock valued at $10,409,000 after purchasing an additional 292,630 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Healthpeak Properties by 13.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 125,507 shares of the real estate investment trust’s stock valued at $2,534,000 after buying an additional 15,009 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Insider Transactions at Healthpeak Properties

In other news, CEO Scott M. Brinker purchased 1,490 shares of the stock in a transaction on Monday, August 4th. The stock was purchased at an average price of $16.83 per share, with a total value of $25,076.70. Following the completion of the transaction, the chief executive officer owned 211,906 shares in the company, valued at approximately $3,566,377.98. The trade was a 0.71% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders bought a total of 8,783 shares of company stock worth $150,129 over the last ninety days. 0.23% of the stock is currently owned by insiders.

Healthpeak Properties Stock Performance

Healthpeak Properties stock opened at $18.75 on Friday. The firm has a market capitalization of $13.03 billion, a P/E ratio of -374.95, a PEG ratio of 3.16 and a beta of 1.09. The stock has a fifty day moving average price of $18.32 and a 200 day moving average price of $17.91. Healthpeak Properties, Inc. has a 52 week low of $16.63 and a 52 week high of $23.12. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC) last released its earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 EPS for the quarter, beating the consensus estimate of $0.45 by $0.01. Healthpeak Properties had a negative return on equity of 0.43% and a negative net margin of 1.36%.The firm had revenue of $705.87 million during the quarter, compared to analyst estimates of $681.65 million. During the same period in the prior year, the firm posted $0.45 earnings per share. The business’s quarterly revenue was up .8% compared to the same quarter last year. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities research analysts anticipate that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a monthly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 19th will be given a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.5%. The ex-dividend date of this dividend is Friday, December 19th. Healthpeak Properties’s payout ratio is 508.33%.

Analyst Upgrades and Downgrades

DOC has been the subject of several research reports. Robert W. Baird set a $21.00 price objective on Healthpeak Properties and gave the stock an “outperform” rating in a report on Wednesday, July 30th. Raymond James Financial raised Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a report on Monday, September 15th. Wells Fargo & Company reduced their price objective on Healthpeak Properties from $20.00 to $18.00 and set an “equal weight” rating for the company in a report on Wednesday, August 27th. Evercore ISI set a $22.00 price target on Healthpeak Properties in a report on Monday, September 15th. Finally, Cantor Fitzgerald began coverage on Healthpeak Properties in a report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price target for the company. Eight analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $21.33.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.